Type 2 diabetes and mild cognitive impairment

Progress in Biochemistry and Biophysics

Volumn 39, Issue 8, 2012, Pages 791-795

  Qu, Mei Hua ^a   Fang, Chun Yan ^a   Zhang, Xiu Rong ^a   Zhao, Chun Zhen ^a   Mao, Shu Mei ^a   Gao, Zhi Qin ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease(AD); Insulin deficiency; Insulin resistant; Mild cognitive impairment(MCI); Type2 diabetes mellitus(T2DM)

Indexed keywords

EID: 84870904643     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2012.00352     Document Type: Review

References (33)

1. de la Monte S M. Insulin resistance and Alzheimer's disease. BMB Rep, 2009, 42( 8): 475-481
2. Biessels G J, Deary I J, Ryan C M. Cognition and diabetes: A lifespan perspective. Lancet Neurol, 2008, 7( 2): 184-190
3. Holtzman D M, Morris J C, Goate A M. Alzheimer's disease: The challenge of the second century. Sci Transi Med, 2011, 3( 77): 77sr1
4. Castellani R J, Rolston R K, Smith M A. Alzheimer's disease. Dis Mon, 2010, 56( 9): 484-546
5. Luchsinger J A. Type 2 diabetes and cognitive impairment: Linking mechanisms. J Alzheimers Dis, 2012, 30( 0): S185-198
6. Zemva J, Schubert M. Central insulin and insulin-like growth factor-1 signaling: Implications for diabetes associated dementia. Curr Diabetes Rev, 2011, 7( 5): 356-366
7. Pasquier F, Boulogne A, Leys D, et al. Diabetes mellitus and dementia. Diabetes Metab, 2006, 32( 5Pt1): 403-414
8. Winocur G, Greenwood C E, Piroli G G, et al. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity. Behav Neurosci, 2005,119(5): 1389-1395 (Pubitemid 41598751)
9. Rivera E J, Goldin A, Fulmer N, et al. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine. J Alzheimers Dis, 2005, 8( 3): 247-268
10. Lester-Coll N, Rivera E J, Soscia S J, et al. Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. J Alzheimers Dis, 2006, 9( 1): 13-33
11. Messier C, Teutenberg K. The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease. Neural Plast, 2005, 12( 4): 311-328
12. Holscher C. Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease. Recent Pat CNS Drug Discov, 2010, 5( 2): 109-117
13. Holscher C, Li L. New roles for insulin-like hormones in neuronal signaling and protection: New hopes for novel treatments of Alzheimer's disease?. Neurobiol Aging, 2010, 31( 9): 1495-1502
14. de la Monte S M. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res, 2012, 9( 1): 35-66
15. de la Monte S M, Longato L, Tong M, et al. Insulin resistance and neurodegeneration: Roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. Curr Opin Investig Drugs, 2009, 10( 10): 1049-1060
16. Farris W, Mansourian S, Leissring M A, et al. Partial loss-offunction mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol, 2004, 164( 4): 1425-1434
17. Frisardi V, Solfrizzi V, Seripa D, et al. Metabolic-cognitive syn -drome: A cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev, 2010, 9( 4): 399-417
18. Yaffe K, Falvey C, Hamilton N, et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia diabetes and risk of cognitive decline. Arch Neurol, 2012, 18( 6): 1-6
19. Auld D S, Kornecook T J, Bastianetto S, et al. Alzheimer's disea -se and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol, 2002, 68(3): 209-245 (Pubitemid 35346805)
20. Lu J, Miao J Y, Pan R, et al. Prog Biochem Biophys, 2011, 38( 12): 1113-1120
21. Xu Y X, Wang H Q, Zhao H, et al. Prog Biochem Biophys, 2011, 38( 10): 908-918
22. Lue L F, Walker D G, Brachova L, et al. Involvement of micr -oglial receptor for advanced glycation endproducts (RAGE) in -Alzheimer's disease: identification of a cellular activation mechan -ism. Exp Neurol, 2001,171(1): 29-45 (Pubitemid 32848443)
23. Wei Y, Han C S, Zhou J, et al. d-ribose in glycation and protein aggregation. Biochim Biophys Acta, 2012, 1820( 4): 488-494
24. de la Monte S M, Wands J R. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J Alzheimers Dis, 2006, 9( 2): 167181
25. Sun P, Zhang Q, Han J Y, et al. TLR4 signaling induced TLR2 expression in the process of mimic cerebral ischemia/reperfiision in vitro. Sci China Life Sci, 2010, 53( 1): 112-124
26. Zhang M, Zhao Z M, He L, et al. A meta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci, 2010, 53( 1): 112-124
27. He R Q, Lu J, Miao J Y. Formaldehyde stress. Sci China Life Sci, 2010, 53( 12): 1399-1404
28. Tong Z Q, Zhang J L, Luo W H, et al. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia. Neurobiology of Aging, 2011, 32: 31-41
29. Xu S J, Liu G L. Prog Biochem Biophys, 2010, 37( 6): 589-593
30. Liu L L, Sheng B Y, Gong K, et al. Prog Biochem Biophys, 2010, 37( 2): 154-160
31. Zhou J W. Recent progress in neurodegenerative disorder research in China. Sci China Life Sci, 2010, 53: 348-355
32. Zhang X H, Poo M M. Progress in neural plasticity. Sci China Life Sci, 2010, 53: 322-329
33. Luo Y F, Zhang J, Liu N Q, et al. Copper ions influence the toxicity of β-amyloid (1-42) in a concentration-dependent manner in a caenorhabditis elegans model of Alzheimer's disease. Sci China Life Sci, 2011, 54( 6): 527-534